Survival impact of amiodarone therapy in heart failure: insights from the Icelandic Heart Failure registry

Back

ESC2025 Premium Access

Survival impact of amiodarone therapy in heart failure: insights from the Icelandic Heart Failure registry

Session: Managing comorbidities in heart failure

Topic: Pharmacotherapy

Speaker: Doctor P. Gudjonsson (Reykjavik, IS)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Doctor Pall Gudjonsson

Landspitali University Hospital, Reykjavik (Iceland)

0 follower

6 more presentations in this session

Stimulation in home based cardiac rehabilitation protocol, the effect on aerobic capacity and quality of life

Speaker: Assistant Professor R. Kallel (Gabes, TN)

Access

Abstract

Slides

The impact of midodrine on patients with heart failure with reduced ejection fraction- retrospective cohort study

Speaker: Doctor J. Mahar (Phoenix, US)

Access

Abstract

Slides

Efficacy and safety of GLP-1 agonists in obesity-related heart failure with preserved ejection fraction: a systematic review and meta-analysis of randomized placebo-controlled trials.

Speaker: Miss J. Khater (Beirut, LB)

Access

Abstract

Slides

Efficacy of intravenous and oral iron replacement therapies in heart failure: a network meta-analysis

Speaker: Mr R. Mizori (London, GB)

Access

Abstract

Slides

Efficacy of liposomal bivalent stabilized iron sulfate in improving iron deficiency and quality of life in patients with chronic heart failure: lower costs for better therapy?

Speaker: Doctor E. Tagliamonte (Nocera Inferiore, IT)

Access

Abstract

Slides

Access the full session

Managing comorbidities in heart failure

Speakers: Doctor P. Gudjonsson, Assistant Professor R. Kallel, Doctor J. Mahar, Miss J. Khater, Mr R. Mizori...

Access

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources

Explore sponsored resources